Attention Deficit Hyperactivity DisorderNCT07803224
Adult ADHD Symptoms, Depression, Anxiety, and Academic Performance in Medical Students
An observational study of Attention Deficit Hyperactivity Disorder and Depression, run by Assiut University.
Trial summary
Attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized to persist into adulthood, often impacting academic performance in university and professional education. This relationship may be further complicated by co-occurring mental health conditions, such as depression and anxiety. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Attention Deficit Hyperactivity Disorder, Depression, Anxiety
- How many people
- 52 participants
- Where
- No sites listed yet
- Study dates
- Oct 2026to Nov 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: The study population consists of undergraduate medical students aged 18 years or older who are currently enrolled at the Faculty of Medicine, Assiut University, Egypt.
Who may be able to join
- Undergraduate students enrolled at the Faculty of Medicine, Assiut University
- Aged 18 years or older
- Willing to participate and provide electronic informed consent
- Able to complete the study questionnaire
Who cannot join
- Postgraduate students or students enrolled in other faculties
- Substantially incomplete questionnaires (missing essential demographic data, academic indicators, or screening scale items)
- Refusal to participate
About this study
Official title: Prevalence of Adult ADHD Symptoms and Their Association With Depression, Anxiety, and Academic Performance Among Medical Students at Assiut University
Attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized to persist into adulthood, often impacting academic performance in university and professional education. This relationship may be further complicated by co-occurring mental health conditions, such as depression and anxiety.
The purpose of this cross-sectional study is to determine the prevalence of adult ADHD symptoms, depressive symptoms, and anxiety symptoms among undergraduate medical students at Assiut University. The study also aims to evaluate how these psychiatric symptoms are associated with academic performance.
Participants will complete a series of self-administered questionnaires, including the Adult ADHD Self-Report Scale (ASRS v1.1), the Patient Health Questionnaire-9 (PHQ-9) for depression, the Generalized Anxiety Disorder-7 (GAD-7) scale for anxiety, a socioeconomic status scale, and demographic/academic information including cumulative grade point average (GPA).
- Keywords
- Adult ADHD, Medical Students, Academic Performance, ASRS v1.1, PHQ-9, GAD-7, Depressive Symptoms, Anxiety Symptoms
- Medical subject headings
- Attention Deficit Disorder with Hyperactivity, Depression, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Undergraduate Medical Students | Undergraduate medical students aged 18 years or older enrolled at the Faculty of Medicine, Assiut University, who complete self-administered questionnaires assessing adult ADHD symptoms (ASRS v1.1), depressive symptoms (PHQ-9), anxiety symptoms (GAD-7), socioeconomic status, and academic performance (cumulative GPA). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of Participants Screening Positive for Adult ADHD Symptoms
Assessed using the 6-item Adult ADHD Self-Report Scale (ASRS v1.1) Arabic version. The scale evaluates the frequency of inattention and hyperactivity/impulsivity symptoms over the preceding 6 months. Each item is rated on a 5-point scale (never, rarely, sometimes, often, very often). A positive screen is defined by meeting the established clinical cutoff threshold (responses falling within shaded/clinically significant boxes), indicating a high likelihood of adult ADHD symptoms.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Sep 2026
- Study startOct 2026 (estimated)
- Primary completionOct 2027 (estimated)
- Study completionNov 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Attention Deficit Hyperactivity DisorderStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 52 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ibrahim Mostafa Ahmed Ibrahim, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07803224
- Sponsor's protocol ID
- Adult ADHD in Medical Students
- Status last verified
- Aug 2026
- First submitted
- 31 Aug 2026
- Last updated
- 3 Sep 2026
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Adult ADHD Symptoms and Their Association With Depression, Anxiety, and Academic Performance Among Medical Students at Assiut University
- ClinicalTrials.gov ID
- NCT07803224
- Acronym / sponsor ID
- Adult ADHD in Medical Students
- Keywords
- Adult ADHD, Medical Students, Academic Performance, ASRS v1.1, PHQ-9, GAD-7, Depressive Symptoms, Anxiety Symptoms
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 52 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- Oct 2026 (estimated)
- Primary completion
- Oct 2027 (estimated)
- Study completion
- Nov 2027 (estimated)
- First posted
- 3 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized to persist into adulthood, often impacting academic performance in university and professional education. This relationship may be further complicated by co-occurring mental health conditions, such as depression and anxiety.
The purpose of this cross-sectional study is to determine the prevalence of adult ADHD symptoms, depressive symptoms, and anxiety symptoms among undergraduate medical students at Assiut University. The study also aims to evaluate how these psychiatric symptoms are associated with academic performance.
Participants will complete a series of self-administered questionnaires, including the Adult ADHD Self-Report Scale (ASRS v1.1), the Patient Health Questionnaire-9 (PHQ-9) for depression, the Generalized Anxiety Disorder-7 (GAD-7) scale for anxiety, a socioeconomic status scale, and demographic/academic information including cumulative grade point average (GPA).
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Undergraduate Medical Students | – | –Undergraduate medical students aged 18 years or older enrolled at the Faculty of Medicine, Assiut University, who complete self-administered questionnaires assessing adult ADHD symptoms (ASRS v1.1), depressive symptoms (PHQ-9), anxiety symptoms (GAD-7), socioeconomic status, and academic performance (cumulative GPA). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- The study population consists of undergraduate medical students aged 18 years or older who are currently enrolled at the Faculty of Medicine, Assiut University, Egypt.
Key inclusion criteria (4 listed)
- Undergraduate students enrolled at the Faculty of Medicine, Assiut University
- Aged 18 years or older
- Willing to participate and provide electronic informed consent
- Able to complete the study questionnaire
Key exclusion criteria (3 listed)
- Postgraduate students or students enrolled in other faculties
- Substantially incomplete questionnaires (missing essential demographic data, academic indicators, or screening scale items)
- Refusal to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Percentage of Participants Screening Positive for Adult ADHD Symptoms
Time frame: Baseline
Assessed using the 6-item Adult ADHD Self-Report Scale (ASRS v1.1) Arabic version. The scale evaluates the frequency of inattention and hyperactivity/impulsivity symptoms over the preceding 6 months. Each item is rated on a 5-point scale (never, rarely, sometimes, often, very often). A positive screen is defined by meeting the established clinical cutoff threshold (responses falling within shaded/clinically significant boxes), indicating a high likelihood of adult ADHD symptoms.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Sep 2026.
Related trials for Attention Deficit Hyperactivity Disorder
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingObservational study
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Disruptive Behavior Disorders, Conduct Disorder
Recruiting
Micronutrient Supplementation and Chronotherapy in Children With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
RecruitingPhase 3
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Attention Deficit Hyperactivity Disorder and Depression, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of Participants Screening Positive for Adult ADHD Symptoms (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.